Treatment of Severe Steroid-Refractory Acute-Graft-vs.-Host Disease With Mesenchymal Stem Cells–Single Center Experience

The most effective treatment of steroid refractory acute graft vs. host disease (aGvHD) is not yet established and mesenchymal stem cells (MSC) appear to be a promising therapy for the condition. We report single center case series of three patients, who underwent allogeneic hematopoietic cell trans...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Bioeng Biotechnol
Autors principals: Česen Mazič, Maja, Girandon, Lenart, Kneževič, Miomir, Avčin, Simona L., Jazbec, Janez
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2018
Matèries:
Bioengineering and Biotechnology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6066564/
https://ncbi.nlm.nih.gov/pubmed/30087891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2018.00093
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars